Texas House passes bill regulating elective IV therapy to prevent patient deaths

The Senate Committee on Health and Human Services convened on May 21, 2025, to discuss House Bill 3749, which aims to regulate the administration of elective intravenous (IV) therapies in Texas. The bill was prompted by the tragic death of a patient who received IV therapy from an unqualified individual, highlighting the need for stricter oversight in this growing industry.

The primary focus of the bill is to restrict the delegation of elective IV therapies to licensed professionals, specifically registered nurses (RNs), advanced practice registered nurses (APRNs), and physician assistants (PAs). During the meeting, concerns were raised about the proliferation of unregulated IV therapy services, often referred to as a "cottage industry," which includes mobile IV bars and hydration clinics. The bill's author emphasized the importance of establishing clear statutory standards to prevent further tragedies and ensure patient safety.

Senator Campbell, a key figure in the discussion, underscored the potential risks associated with IV therapy, particularly regarding the administration of fluids and medications without proper oversight. He noted that even experienced medical professionals must exercise caution when administering IV treatments, as improper administration can lead to serious complications.

Several witnesses testified in support of the bill, including paramedics who expressed concern that the legislation, as currently written, would exclude them from providing elective IV therapy under physician supervision. They argued that paramedics are trained professionals capable of safely administering IV treatments and that their exclusion could limit patient access to care. The paramedics called for amendments to the bill to include their services, emphasizing their role in emergency response and preventative health care.

The committee also discussed the operational aspects of mobile IV therapy services, including the protocols for physician oversight and the training required for paramedics. Questions were raised about the accountability of these services and the potential risks to patients if they are not adequately regulated.

As the meeting progressed, it became clear that while the intent of House Bill 3749 is to enhance patient safety, there is a significant debate regarding the scope of who should be allowed to administer elective IV therapies. The committee plans to continue reviewing the bill and considering amendments to address the concerns raised by various stakeholders.

In conclusion, the Senate Committee on Health and Human Services is taking steps to regulate the elective IV therapy industry in Texas, aiming to balance patient safety with access to care. Further discussions and potential amendments to House Bill 3749 are expected as the committee seeks to finalize the legislation.